• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Indo US Bio-Tech reports standalone net loss of Rs 3.67 crore in the September 2026 quarter
Oct 30,2026
Net loss of Indo US Bio-Tech reported to Rs 3.67 crore in the quarter ended September 2026 as against net profit of Rs 3.45 crore during the previous quarter ended September 2025. Sales declined 51.22% to Rs 15.05 crore in the quarter ended September 2026 as against Rs 30.85 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales15.0530.85 -51
OPM %-17.3413.48 -
PBDT-3.373.77 PL
PBT-3.653.56 PL
NP-3.673.45 PL